Literature DB >> 26909647

Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.

Joo Hyun O1, Martin A Lodge1, Richard L Wahl1.   

Abstract

Positron Emission Tomography (PET) Response Criteria in Solid Tumors (PERCIST 1.0) describes in detail methods for controlling the quality of fluorine 18 fluorodeoxyglucose PET imaging conditions to ensure the comparability of PET images from different time points to allow quantitative expression of the changes in PET measurements and assessment of overall treatment response in PET studies. The steps for actual application of PERCIST are summarized. Several issues from PERCIST 1.0 that appear to require clarification, such as measurement of size and definition of unequivocal progression, also are addressed. (©) RSNA, 2016.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26909647      PMCID： PMC4976461          DOI： 10.1148/radiol.2016142043

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  14 in total

1.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Authors:  Lalitha K Shankar; John M Hoffman; Steve Bacharach; Michael M Graham; Joel Karp; Adriaan A Lammertsma; Steven Larson; David A Mankoff; Barry A Siegel; Annick Van den Abbeele; Jeffrey Yap; Daniel Sullivan
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

2.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

3.  Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.

Authors:  Michael M Graham; Richard L Wahl; John M Hoffman; Jeffrey T Yap; John J Sunderland; Ronald Boellaard; Eric S Perlman; Paul E Kinahan; Paul E Christian; Otto S Hoekstra; Gary S Dorfman
Journal:  J Nucl Med       Date:  2015-04-16       Impact factor: 10.057

4.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

5.  Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.

Authors:  Mitsuaki Tatsumi; Christian Cohade; Yuji Nakamoto; Richard L Wahl
Journal:  Radiology       Date:  2003-10-30       Impact factor: 11.105

6.  Optimum lean body formulation for correction of standardized uptake value in PET imaging.

Authors:  Abdel K Tahari; David Chien; Javad R Azadi; Richard L Wahl
Journal:  J Nucl Med       Date:  2014-06-24       Impact factor: 10.057

Review 7.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

8.  Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.

Authors:  Masahiro Yanagawa; Mitsuaki Tatsumi; Hiroshi Miyata; Eiichi Morii; Noriyuki Tomiyama; Tadashi Watabe; Kayako Isohashi; Hiroki Kato; Eku Shimosegawa; Makoto Yamasaki; Masaki Mori; Yuichiro Doki; Jun Hatazawa
Journal:  J Nucl Med       Date:  2012-05-11       Impact factor: 10.057

9.  Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Authors:  Kristin Skougaard; Dorte Nielsen; Benny Vittrup Jensen; Helle Westergren Hendel
Journal:  J Nucl Med       Date:  2013-04-09       Impact factor: 10.057

10.  Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria.

Authors:  D Ziai; T Wagner; A El Badaoui; A Hitzel; J B Woillard; B Melloni; J Monteil
Journal:  Cancer Imaging       Date:  2013-03-05       Impact factor: 3.909
View more
  106 in total

1.  Bacterial infection imaging with [18F]fluoropropyl-trimethoprim.

Authors:  Mark A Sellmyer; Iljung Lee; Catherine Hou; Chi-Chang Weng; Shihong Li; Brian P Lieberman; Chenbo Zeng; David A Mankoff; Robert H Mach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT.

Authors:  Wei Chen; Lei Zhu; Xiaozhou Yu; Qiang Fu; Wengui Xu; Ping Wang
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

Review 3.  [Importance of FDG-PET/computed tomography in colorectal cancer].

Authors:  S Kleiner; W Weber
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

4.  Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.

Authors:  Hebert Alberto Vargas; Gem M Kramer; Andrew M Scott; Andrew Weickhardt; Andreas A Meier; Nicole Parada; Bradley J Beattie; John L Humm; Kevin D Staton; Pat B Zanzonico; Serge K Lyashchenko; Jason S Lewis; Maqsood Yaqub; Ramon E Sosa; Alfons J van den Eertwegh; Ian D Davis; Uwe Ackermann; Kunthi Pathmaraj; Robert C Schuit; Albert D Windhorst; Sue Chua; Wolfgang A Weber; Steven M Larson; Howard I Scher; Adriaan A Lammertsma; Otto S Hoekstra; Michael J Morris
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

5.  Novel Structured Reporting Systems for Theranostic Radiotracers.

Authors:  Rudolf A Werner; Ralph A Bundschuh; Lena Bundschuh; Stefano Fanti; Mehrbod S Javadi; Takahiro Higuchi; Alexander Weich; Kenneth J Pienta; Andreas K Buck; Martin G Pomper; Michael A Gorin; Ken Herrmann; Constantin Lapa; Steven P Rowe
Journal:  J Nucl Med       Date:  2019-02-22       Impact factor: 10.057

6.  PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Authors:  Oke Gerke; Karen Ehlers; Edith Motschall; Poul Flemming Høilund-Carlsen; Werner Vach
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 7.  Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.

Authors:  F Edward Boas; Lisa Bodei; Constantinos T Sofocleous
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

8.  PERCIST in Perspective.

Authors:  Joo Hyun O; Richard L Wahl
Journal:  Nucl Med Mol Imaging       Date:  2017-12-18

9.  Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients.

Authors:  Lotte Nygård; Marianne C Aznar; Barbara M Fischer; Gitte F Persson; Charlotte B Christensen; Flemming L Andersen; Mirjana Josipovic; Seppo W Langer; Andreas Kjær; Ivan R Vogelius; Søren M Bentzen
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

10.  Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

Authors:  Vadim S Koshkin; Vanessa Bolejack; Lawrence H Schwartz; Richard L Wahl; Rashmi Chugh; Denise K Reinke; Binsheng Zhao; Joo H O; Shreyaskumar R Patel; Scott M Schuetze; Laurence H Baker
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.